PrEP4All (37 Articles with 35,308 total views)
Igniting political action to put lifesaving HIV prevention medication, paid for by the American taxpayer, in the hands of the people who need it most.
February, 2026
STATEMENT: PrEP Users Applaud CVS and Gilead Agreement on Yeztugo
New York, NY, January 13, 2026- PrEP4All and the PrEP Users Union welcome the news that Gilead Sciences and CVS Caremark have finally reached a deal to include lenacapavir (brand name Yeztugo), a groundbreaking six-month injectable version of PrEP, on CVS's drug formulary. In October, PrEP4All and the Union sent a sign on letter from over 500 PrEP users and supporters to leadership at both companies, urging them to uphold their stated corporate commitments to equitable healthcare, and prioritize access to lenacapavir over profit. The PrEP users' letter secured an unusually transparent response from CVS expressing frustration over the high price set by Gilead for the long acting injectable PrEP.
January, 2026
Save HIV Funding Responds to Reports That HIV Rates in New York City Have Risen, Amid Proposed Federal Cuts to Essential and Life-Saving HIV Programs
New York, NY - Wednesday, December 10, 2025 - In response to news that HIV rates have risen in New York City, the Save HIV Funding Campaign today released a statement calling on New Yorkers to contact their federal representatives and let them know that cutting vital federal investment in HIV infrastructure would be devastating to their communities. According to the New York City Department of Health and Mental Hygiene's HIV Surveillance Annual Report, 2024, New York City saw a 5.4% increase in 2024 (or 1,791 new HIV diagnoses). As reported in The Gothamist, this follows a 6.9% increase from 2022 to 2023. While these increases happened before recent disruptions to domestic HIV funding, current threats to funding and infrastructure will only further increase HIV rates, as well as racial and gender disparities.
December, 2025
Ahead of World AIDS Day, Save HIV Funding Campaign Releases Updated Funding Fast Facts, Announces National Week of Action
WASHINGTON, D.C, TUESDAY, NOVEMBER 25, 2025 - In advance of World AIDS Day, taking place on December 1, the #SaveHIVFunding campaign has released a newly updated Action Alert, and announced a coordinated national week of actionwith partner organizations to call on Congress to reject proposed federal cuts that would jeopardize vital HIV prevention, care, and treatment programs. Save HIV Funding encourages journalists, creators and advocates reporting on World AIDS Day this year to include the story and narrative around the current state of HIV funding and has provided a refreshed list of HIV Funding Fast Facts at the end of this release.
November, 2025
From Capitol Hill to a global audience - join the #CutsKill Digital Quilt
The #CutsKill Quilt, inspired by the AIDS Memorial Quilt of the 1980s, was unveiled at the U.S. Capitol on September 5, 2025 as a powerful visual installation highlighting the lives at stake if federal HIV funding is cut. The quilt honors the past while warning Congress of the devastating consequences that could follow without immediate action to protect lifesaving care.
October, 2025
Statement by PrEP4All's Executive Director on RFK Jr.'s Firing of CDC Director
NEW YORK, NY - August 28, 2025 - In response to Health Secretary Robert F. Kennedy Jr.'s attempted firing of CDC Director Susan Monarez for refusing to abandon scientific evidence, PrEP4All Executive Director Jeremiah Johnson released the following statement: "We stand with the CDC leaders calling attention to the anti-science agenda at HHS. We also urge that Congress must act now to protect the independence of the Preventive Services Task Force. The attempted firing of the CDC Director for refusing to 'rubber-stamp unscientific, reckless directives' underscores the urgent need to safeguard other medical experts who refuse to put ideology ahead of science. U.S. Preventive Services Task Force experts could be next.
August, 2025
National Coalition of HIV, LGBTQ+ and Health Advocates Applauds Court Decision Upholding Law that Ensures Access to PrEP &other Healthcare Preventive Services
(Washington, DC - June 27) This Pride Month, we have been inundated by threats to the LGBTQ community-from book bans to attacks on gender-affirming care. But one case before the Supreme Court has stood out in its potential to inflict devastating harm far beyond our community. Kennedy v. Braidwood has been not just an attack on HIV prevention or LGBTQ people-it has been a coordinated effort to dismantle access to no-cost preventive healthcare for more than 150 million Americans.
July, 2025
NEW! Save HIV Funding Website + #PrideIsAProtest Action Alert
Save HIV Funding Campaign organizers want to remind everyone that the first Pride was a protest. At savehivfunding.org, we have also launched the #PrideIsAProtest Action Alert at a critical time when advocates are fighting The White House’s so-called “Big, Beautiful Bill” which seeks to slash Medicaid, Medicare, and other programs essential to the wellbeing of people living with and vulnerable to HIV infection. At the same time, the President’s 2026 Budget Request proposes devastating HIV prevention and research cuts. Now is the time for people living with HIV, advocates, allies, and communities nationwide to denounce these cuts and urge their Senators and members of Congress to protect access to healthcare including HIV prevention and treatment, housing, food assistance, and many other critical supports relied on by people nationwide.
PrEP Users' Union Launches Storybank to Uplift Voices of PrEP Users
Building on the #PrEPSaves campaign, PrEP4All's PrEP Users' Union has launched a storybank to highlight the diverse voices of current and former PrEP users. With widespread threats to funding for HIV prevention programs and research, it is more important than ever that PrEP users' experiences are uplifted in HIV prevention policy discussions. We are incredibly grateful to Johns Hopkins University for helping support this project.
PrEP4All Statement on FDA Approval of Lenacapavir as PrEP
The long-anticipated approval of lenacapavir as a once every six-month injectable option for PrEP is a welcome development in the fight to end HIV as an epidemic. It is also a testament to the value and power of American taxpayer investment in the research at the National Institutes of Health that set the stage for this groundbreaking advancement. However, the path to access is more perilous than ever for the communities in greatest need of PrEP, and it is far from clear that innovation will triumph over the expensive price Gilead has set for lenacapavir coupled with active efforts by the Trump administration and Congressional Republicans to dismantle HIV prevention and healthcare systems in America.
STATEMENT: Trump Budget Request Retreats on Ending the HIV Epidemic
The President's FY26 Budget Request released on Friday proposes draconian cuts to HIV prevention, care, housing, and research which would jeopardize decades of effective programs that have consistently delivered outstanding results by saving lives, preventing new cases of HIV, and reducing health care costs. In addition to proposing dramatic funding reductions, the Administration suggests a new health care agency - the Administration for a Healthy America (AHA) - lead on major HIV workstreams without providing details on how this new agency will continue to support and deliver the same high level of HIV programming with outstanding outcomes and valuable returns. Congress must reject these devastating cuts as well as halt efforts to move federal HIV activities into the poorly defined AHA.
June, 2025
GLAAD and LGBTQ Community Advocacy Organizations Respond to U.S. Supreme Court Oral Arguments Heard in Kennedy V. Braidwood Case
New York, New York - Monday, April 21, 2025 GLAAD, the world's largest LGBTQ (lesbian, gay, bisexual, transgender, and queer) media advocacy organization, together with a community advocacy coalition led by Lambda Legal, PrEP4All, Harvard Law's Center for Health Law and Policy Innovation (CHLPI), and The Center for HIV Law and Policy (CHLP), today released statements following oral arguments in the Braidwood case heard before the U.S. Supreme Court this morning.
Trump Budget Proposal Confirms HIV Advocates' Worst Fears
May 5, 2025 (New York, NY) The topline FY26 budget request released by the Trump administration on Friday would decimate domestic HIV prevention, treatment, and research while derailing U.S. work toward ending the HIV epidemic. The cuts would destroy the decades-long bipartisan response to HIV by cutting and reorganizing HIV programs within the Department of Health and Human Services (HHS) without the input of people living with HIV, state and local health departments, medical providers, and other experts. The budget request ominously omits mention of key HIV initiatives and offices, including the Ending the HIV Epidemic initiative, the CDC's Division of HIV Prevention, and both the SAMHSA and HHS Minority AIDS Funds.
May, 2025
STATEMENT: Advocates Denounce Draconian Cuts to Federally Funded HIV Infrastructure
People living with and vulnerable to HIV, along with HIV providers, scientists, and advocates, face a draconian tipping point: the Trump Administration proposes to radically cut HIV prevention, treatment, and research for life-saving and cost-saving services and interventions. In recent weeks, several offices of critical importance to the national HIV response within the Department of Health and Human Services, or HHS, have been targeted for severe program and staffing cuts. If there were any doubt of the administration's intent to neuter federally funded HIV infrastructure, this week a leaked copy of the administration's forthcoming FY 2026 HHS budget request would clearly eviscerate funding for HIV prevention, research and other efforts to end HIV as an epidemic.
April, 2025
STATEMENT: Cuts to HIV, STI, Hepatitis, and TB Prevention will Cost Lives, Jobs, and Money
The HIV community has heard that the Trump Administration may severely cut and possibly eliminate HIV programs and funding at CDC, including in the Division of HIV Prevention (DHP). Cuts to DHP would impact the work & viability of the entire National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Such a dramatic reduction in and reorganization of resources would result in many new cases of HIV and increase the already large numbers of people with STIs. Doing so will result in thousands of new cases of HIV, open the way for babies to be born with HIV, and lead to shorter lives and fewer resources for many people, creating even more missed opportunities for good health through HIV prevention.
March, 2025
Ending HIV Requires a Functional US Democracy & Government
The rapid dismantling of US democratic norms over the past 3 weeks - including fundamental government protections and structures - threatens the nation's democracy, diversity, society, and economy. The decline of a functional American democracy impacts all citizens, but especially the people whom leaders now target, including BIPOC communities, LGBTQ+ people, immigrants, and women. These dramatic and dangerous changes impact people needing and advocating for HIV prevention, treatment and research, including expanding access to PrEP. Congress and leaders nationwide, including PrEP4All, must stand up to this dangerous turn in government and demand an Administration that leads with democratic norms and supports strategic, compassionate US governance.
November, 2024
NEW REPORT: The Pathway Forward for a National PrEP Program
This year, PrEP4All convened over 50 PrEP users, providers, community leaders, health department representatives, and researchers from around the country to discuss best practices for achieving equity in a National PrEP Program. Following meetings hosted at the Johns Hopkins Bloomberg School of Public Health and the Emory University Rollins School of Public Health, PrEP4All has released top level recommendations in our latest report, The Path Forward for a National PrEP Program: Policy and Implementation Priorities. An accompanying summary document is also available. PrEP4All sincerely thanks Arnold Ventures for its support of this critical work.
October, 2024
PrEP4All Statement on Interim PURPOSE 2 Results
September 12, 2024 - Today, Gilead Sciences announced early interim results from its PURPOSE 2 trial demonstrating that among men who have sex with men, transgender, and nonbinary individuals lenacapavir administered as a once every six-month injectable PrEP resulted in an HIV rate that was 96% lower compared with expected background levels of new HIV infections and 89% lower compared with oral TDF/FTC. Following on the early results of PURPOSE 1 in cisgender women in sub-Saharan Africa, which showed no new HIV infections in the lenacapavir arm, the company is prepared to seek regulatory approval in hopes of coming to market in 2025.
STATEMENT: National PrEP Advocates Applaud CDC PrEP Pilot Launch
Thursday, October 4th, 2024- Advocates applaud the announcement of the five jurisdictions to receive funding as part of a first-of-its-kind Centers of Disease Control and Prevention (CDC) PrEP pilot. While the original notification of funding opportunity (NOFO) allocated $7M in funds for four jurisdictions, in the face of overwhelming demand from 17 health departments who applied, the CDC increased the investment to $10M $2M each for five jurisdictions a clear sign of the urgent need for more PrEP funding. The initiative has the potential to show how a National PrEP Program , as championed by advocacy organizations all over the US, could transform equitable PrEP access by greatly simplifying cost coverage, expanding access to providers, and creating more effective and community-driven education and awareness initiatives. PrEP4All, PrEP in Black America, HIVMA, and AVAC stand ready to work alongside key stakeholders in the five jurisdictions chosen Baltimore, Houston, Florida, Oklahoma, and South Carolina and provide insights from the last three years of multi-stakeholder discussions led by our organizations.
September, 2024
Heeding Community Advocates' Calls, CDC Funds PrEP Pilot Program, Allows Funds to Pay for Generic Medications
Tuesday, August 6th, 2024 For the first time ever, the U.S. Centers for Disease Control and Prevention will allow for funding to pay for generic PrEP medications as part of a new supplemental funding opportunity aimed at quickly scaling up equitable PrEP access in four jurisdictions. Advocates have been calling for such an initiative to serve as a pilot for a National PrEP Program for un- and underinsured individuals; a key component of which would involve the implementation of a user-friendly PrEP Pass that could eliminate cost and complexity as a barrier to medications, HIV testing, necessary lab work, and provider visits.
April, 2024
PrEP4All Launches #PrEPSaves PrEP Users' Union
Since 2018, PrEP4All has led the charge for a federally-funded National PrEP Program, and as the movement has gotten more attention, including calls from the White House to Congress to fund such a program, it is more important now than ever to uplift the voices of PrEP users in key HIV policy discussions. That's why PrEP4All is expanding the groundwork laid with our Summer 2023 #PrEPSaves campaign to launch the #PrEPSaves PrEP Users' Union (P2U).
President Biden Proposes a National PrEP Program for a Third Year in his FY25 Budget Request
PrEP4All welcomes the Biden Administration's ongoing commitment to a National PrEP Program for un- and underinsured individuals in America. For the third year, the Administration has called for a 10-year $9.8B investment in equitable PrEP scale up to erase enormous racial, gender, and geographic disparities in PrEP uptake (see page 6 of the HHS Budget in Brief).
March, 2024
PrEP4All and Over 100 Partner Organizations Tell Congress to #SaveHIVFunding!
In response to an unprecedented proposed $767 million in domestic HIV funding cuts in the House of Representatives, PrEP4All, along with our partners AVAC, HIVMA, PrEP In Black America, NASTAD, the HIV + Hepatitis Policy Institute, The AIDS Institute, AIDS United, NMAC, and several members of the Federal AIDS Policy Partnership launched the #SaveHIVFunding campaign at the United States Conference on HIV/AIDS in Washington DC last Fall. Since then, thousands of advocates and community members, along with over 100 organizations, have joined the fight to demand Congress keep the bipartisan commitment to fund Ending the HIV Epidemic (EHE) activities.
October, 2023
PrEP4All to Embark on Groundbreaking National PrEP Program Discussions
PrEP4All will hold a series of high-level consultations that will advance a strategic conversation on the costs, benefits, and best practices for a National PrEP Program for un- and under-insured individuals in America. The organization will convene key experts and thought leaders to capture the potential value of a National PrEP Program for communities across the United States.
The National Coalition of STD Directors and PrEP4All Urge White House Intervention on Syphilis Drug Shortage
Washington, D.C. - On Monday, a coalition of 39 leading public health groups sent a letter urging the White House Drug Shortage Task Force to prioritize action to end the ongoing shortage of Bicillin L-A. Bicillin L-A is the only approved treatment for syphilis in pregnant women and the preferred treatment for syphilis in adults, infants, and children. Clinics and states have reported being unable to access Bicillin L-A, and Pfizer - the drug's exclusive manufacturer - has reported that they will not resolve the shortage until mid 2024.
September, 2023
PrEP4All, AVAC, HIVMA, and the PrEP In Black America Coalition Applaud Senate Proposal to Increase Key HIV Funding, Build National PrEP Program
July 28, 2023 - Soundly rejecting House efforts to gut HIV funding, yesterday the Senate Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations Subcommittee released its FY24 spending bill which clearly reflects concerted efforts by PrEP activists over the past few months to prioritize support for a national PrEP program. The Senate bill would allocate $616 million in funding for the Ending the HIV Epidemic (EHE), including a $3 million increase to CDC that specifically "support[s] the building blocks for a national program to increase…PrEP (pg. 60)."
August, 2023
PrEP4All and the Elton John AIDS Foundation Announce Strategic Partnership to Advance a National PrEP Program
PrEP4All is proud to announce that our work to ensure equitable PrEP access for all in the United States will be supported by a two-year investment totaling nearly $670,000 from the Elton John AIDS Foundation. This new strategic partnership comes at a pivotal point in the movement for a National PrEP Program for uninsured and underinsured individuals in the United States. PrEP4All, a nonprofit dedicated to equitable PrEP access, was the first organization to call for such a program shortly after its foundation in 2018.
July, 2023
PrEP4All and PIPLI Commend DOJ for Continuing to Press Its Case in U.S. v. Gilead
PrEP4All commends the Department of Justice (DOJ) for taking action and urging a Delaware federal judge to overturn the recent verdict in US v. Gilead, which, should it stand, would let Gilead off the hook for infringing on patents held by the federal government. On May 17th, PrEP4All along with the Public Interest Patent Law Institute (PIPLI) and with legal representatives from Columbia Law School's Science, Health, and Information Clinic released a statement expressing extreme disappointment in the verdict in U.S. v. Gilead and calling on DOJ to continue to press its case and potentially call for a new trial.
Register Now for PrEP In Black America’s Mpox Webinar
Calling all public health and sexual health activists! Please join PrEP4All, PrEP In Black America, Treatment Action Group, and AVAC on Tuesday, June 20, 2023, for a webinar on mpox. We'll cover the latest research and updates on how vaccines and treatments work, risk factors for severe symptoms and disease, and the ongoing fight to address disparities in infection rates and uptake of vaccines, treatments and tests that impact Black communities.
May, 2023
PrEP Advocates Convene Virtual Town Hall Responding to Braidwood v. Becerra
Thursday, April 6th, 2023, New York, NY- Hundreds of HIV prevention advocates nationwide convened on Tuesday to discuss the implications of Judge Reed O'Connor's ruling in the Texas Braidwood v. Becerra case that could impact access to PrEP and other preventive health interventions for millions of Americans. The ruling states private insurers are no longer required to cover certain preventive care services under the Affordable Care Act, including PrEP.
Science Held Hostage: PrEP4All Exposes Big Pharma's Efforts to Delay Innovative, Lifesaving COVID-19 Research in Investigative Report
New York, NY - April 18, 2023 - The Biden Administration's "Project Next Gen" initiative for new pandemic-focused vaccines and treatments could be delayed by months or even years by pharmaceutical companies that will not make current SARS CoV-2 vaccines readily available for pre-clinical and clinical research, according to PrEP4All. This is the conclusion from the advocacy organization's new report, released today, titled "Science Held Hostage: How Pharma is Using mRNA Vaccine Contracts With Government to Delay Future Innovation." The publication details how pharmaceutical companies are using language from contracts inked in the earliest days of the pandemic as an excuse for delaying access to their vaccines. The report also reveals that US government funding is being used to purchase generic versions of Pfizer's mRNA vaccine for use in pre-clinical research.
April, 2023
Judge in US v. Gilead Responds to Calls for Transparency; Presses Gilead and DOJ to Justify Excessive Redactions and Sealing in Key Public Filings
Wilmington, DE - March 28, 2023 - On March 20, Judge Maryellen Noreika, presiding judge in the landmark patent infringement case United States v. Gilead Sciences, called for a hearing to review both the U.S. government and Gilead Sciences' reasons for excessive secrecy in their public case filings. The hearing will take place on April 4. This move follows a March 14 letter sent to the judge by Columbia Law School's Science, Health & Information Clinic on behalf of PrEP4All and the Public Interest Patent Law Institute (PIPLI), which flagged pervasive and unjustified redactions by Gilead and the U.S. government alike, requested justification for the parties' secrecy, and requested submission of new, less heavily redacted versions of their filings. Judge Noreika's call for a hearing marks a win for PrEP4All, PIPLI, and public interest and transparency advocates more broadly, as it indicates that she is concerned that the U.S. government and Gilead have improperly shielded much of their evidence and legal arguments from public view. PIPLI and PrEP4All applaud the Judge's rapid response to their letter calling for transparency.
PrEP4All Appreciates Ongoing Biden Commitment to National PrEP Program in FY24 Budget
(New York, NY) As part of his FY24 Budget Request released last week, President Biden once again included a $9.8B ten-year proposal for a National PrEP Program. PrEP4All reiterates its gratitude for this vision for a robust PrEP program, which was first proposed last year, and appreciates the Administration's ongoing commitment to establish a National PrEP Program. As we approach 11 years since FDA approval of PrEP, advocates urge the White House to move forward as soon as possible to put in place a national PrEP initiative using discretionary funding to more quickly increase PrEP equity and end current disparities based on race, ethnicity, gender and geography. Increased PrEP access and uptake also would improve health outcomes and reduce health care costs.
PrEP4All To Hold Emergency Virtual Town Hall this Tuesday In Response To Braidwood v. Becerra
PrEP4All and the HIV advocacy community are outraged at U.S. District Judge Reed O'Connor's decision in Braidwood v. Becerra, striking the requirement that most insurers cover a range of critical preventive services such as PrEP, HIV testing, STD screening, cancer screenings, diabetes screenings, and more . PrEP4All, joined by AVAC, HIV Medicine Association, Center for HIV Law & Policy, Lambda Legal, and other HIV prevention advocates, will host an emergency virtual town hall on Tuesday, April 4, 2023 at 6:00 PM ET. We will help the community better understand the implications of Judge Reed's ruling and discuss next advocacy steps to ensure those in need of PrEP can access it.
Register Now For Second PrEP In Black America Summit New Orleans, LA May 19, 2023
Join Black HIV prevention advocates from across the U.S. for the second interactive PrEP In Black America Summit in New Orleans, LA on May 19, as we develop and build on existing strategies to increase PrEP access and awareness in the Black community. Thanks to continued support from The Red Hot Organization, we are able to offer the PrEP In Black America Summit at no cost to advocates and community members.
March, 2023
Black HIV Advocates Release "Master Plan for HIV Prevention" and Announce Next PrEP In Black America Summit in New Orleans, LA
Atlanta, GA-On National Black HIV/AIDS Awareness Day (Feb. 7), Black HIV Prevention advocates released "For Us By Us: PrEP In Black America: A Master Plan for HIV Prevention In Black America", a roadmap to drastically scale-up use of pre-exposure prophylaxis (PrEP) in the Black community. PrEP is a biomedical tool used to reduce the risk of acquiring HIV by over 99%. The report, which covers findings from the PrEP In Black America Summit held in Atlanta, GA on September 13, 2022, was compiled by researchers in the iSTRIVE Lab, with evaluation data compiled by Muse Research, LLC.
NEJM: PrEP4All and Killelea Consulting Make the Case for Investing in National HIV PrEP Preparedness
New York, NY - February 27, 2023 - In a new Perspectives article, "Investing In National HIV PrEP Preparedness ," published on February 25th in the New England Journal of Medicine, PrEP4All's Acting Executive Director Jeremiah Johnson and former Managing Director of Advocacy & Organizing Kenyon Farrow along with Amy Killelea of Killelea Consulting and Johns Hopkins University make the case for the Biden Administration, Congress, and the Centers for Disease Control and Prevention (CDC) to immediately advance a National PrEP Program as part of a broader effort to improve public health responses for marginalized communities.
February, 2023
Register for PrEP In Black America's "The Power Of PrEP" Webinar On February 7, National Black HIV/AIDS Awareness Day
Just two months after the ten-year anniversary of Food and Drug Administration approval of PrEP, Black advocates gathered in Atlanta, GA at our inaugural PrEP in Black America Summit to address the dismal PrEP utilization rates in the Black community. On National Black HIV/AIDS Awareness Day, we will gather again at our "The Power of PrEP" webinar to discuss the outcomes of the Summit and preview a roadmap that will serve as a framework to increase PrEP uptake in the Black community and help end the HIV epidemic
PrEP4All
Igniting political action to put lifesaving HIV prevention medication, paid for by the American taxpayer, in the hands of the people who need it most.
Connect With Us
